Catherine A. Sohn - Mar 23, 2023 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/ Richard Eisenstadt, as Attorney-in-Fact
Stock symbol
ALT
Transactions as of
Mar 23, 2023
Transactions value $
$0
Form type
4
Date filed
3/27/2023, 04:17 PM
Previous filing
Aug 9, 2022
Next filing
Aug 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALT Stock Options (option to buy) Award $0 +47K $0.00 47K Mar 23, 2023 Common Stock, par value $0.0001 47K $4.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option become vested and exercisable in 36 substantially equal monthly installments following March 23, 2023, subject to the reporting person's continued service through the applicable vesting